Toru Kodo - Concepedia

Author

Toru Kodo

Sumitomo Dainippon Pharma (Japan)

Also Known As

Kodo, Toru, T. KODO, Toru Kodo

Publications

201

Citations

H-Index

Concepts

All Affiliations

Sumitomo Dainippon Pharma (Japan)

About

Toru Kodo is an author at Sumitomo Dainippon Pharma (Japan) specializing in neuropharmacology, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	123
2	Biochemistry	3	3	123
3	Pharmacology	3	3	123
4	Natural Sciences	2	2	96
5	Chemical Biology	1	1	71

Toru Kodo

Publications

188

Citations

H-Index

Page 1

	Year	Citations
Tricyclic Quinoxalinediones: 5,6-Dihydro-1H-pyrrolo[1,2,3-de]quinoxaline-2,3-diones and 6,7-Dihydro-1H,5H-pyrido[1,2,3-de]quinoxaline-2,3-diones as Potent Antagonists for the Glycine Binding Site of the NMDA Receptor Ryu Nagata, Norihiko Tanno, Toru Kodo, Journal of Medicinal Chemistry Combinatorial ChemistryPharmacotherapyHeterocycle ChemistryChemical BiologyPharmaceutical Chemistry	1994	71
Design, synthesis and structure–activity relationships of novel benzoxazolone derivatives as 18 kDa translocator protein (TSPO) ligands Takayuki Fukaya, Toru Kodo, Takeo Ishiyama, Bioorganic & Medicinal Chemistry	2012	32
Structure-activity relationships of tricyclic quinoxalinediones as potent antagonists for the glycine binding site of the NMDA receptor 2 Ryu Nagata, Toru Kodo, Hiroshi Yamaguchi, Bioorganic & Medicinal Chemistry Letters Nmda Receptor 2BiochemistryFunctional SelectivityMedicineMechanism Of Action	1995	27
Tricyclic Indole-2-carboxylic Acids: Highly in Vivo Active and Selective Antagonists for the Glycine Binding Site of the NMDA Receptor Seiji Katayama, Nobuyuki Ae, Toru Kodo, Journal of Medicinal Chemistry Nmda-glycine Binding SitePharmacotherapyPharmaceutical ChemistryMedicinal ChemistryNeurochemistry	2003	25
Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancreatic cancer Sadanori Watanabe, Akitada Yogo, Tsuguteru Otsubo, BMC Cancer	2022	20
Design, synthesis and structure–activity relationship of novel tricyclic benzimidazolone derivatives as potent 18 kDa translocator protein (TSPO) ligands Takayuki Fukaya, Toru Kodo, Takeo Ishiyama, Bioorganic & Medicinal Chemistry	2012	13

Page 1